• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Attitude towards genetic testing for breast cancer susceptibility genes and choice of prevention strategies in Chinese women with or without breast cancer.

作者信息

Yu Xue, Kou Furong, Xie Yuntao

机构信息

Department of Breast Surgery, Peking University International Hospital, Beijing 102206, China.

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Comprehensive Clinical Trial Ward, Peking University Cancer Hospital & Institute, Beijing 100142, China.

出版信息

Cancer Biol Med. 2025 Feb 4;22(1):28-32. doi: 10.20892/j.issn.2095-3941.2024.0519.

DOI:10.20892/j.issn.2095-3941.2024.0519
PMID:39907101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11795268/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb39/11795268/948607e3a9a4/cbm-22-028-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb39/11795268/948607e3a9a4/cbm-22-028-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb39/11795268/948607e3a9a4/cbm-22-028-g001.jpg

相似文献

1
Attitude towards genetic testing for breast cancer susceptibility genes and choice of prevention strategies in Chinese women with or without breast cancer.中国患乳腺癌和未患乳腺癌女性对乳腺癌易感基因检测的态度及预防策略选择
Cancer Biol Med. 2025 Feb 4;22(1):28-32. doi: 10.20892/j.issn.2095-3941.2024.0519.
2
Attitude towards hereditary cancer risk management among women with cancer in Taiwan.台湾癌症女性对遗传性癌症风险管理的态度。
Support Care Cancer. 2022 Apr;30(4):3625-3632. doi: 10.1007/s00520-021-06742-4. Epub 2022 Jan 14.
3
'A low risk is still a risk': exploring women's attitudes towards genetic testing for breast cancer susceptibility in order to target disease prevention.“低风险仍是风险”：探索女性对乳腺癌易感性基因检测的态度以实现疾病预防目标
Public Health Genomics. 2011;14(4-5):238-47. doi: 10.1159/000276543. Epub 2010 Jan 14.
4
Attitude towards genetic testing for breast cancer susceptibility: a comparison of affected and unaffected women.乳腺癌易感性基因检测态度：患者与非患者女性的比较。
Eur J Cancer Care (Engl). 2010 May;19(3):360-8. doi: 10.1111/j.1365-2354.2009.01067.x. Epub 2009 Nov 13.
5
A qualitative study on Singaporean women's views towards breast cancer screening and Single Nucleotide Polymorphisms (SNPs) gene testing to guide personalised screening strategies.一项关于新加坡女性对乳腺癌筛查和单核苷酸多态性（SNP）基因检测以指导个体化筛查策略的看法的定性研究。
BMC Cancer. 2017 Nov 21;17(1):776. doi: 10.1186/s12885-017-3781-8.
6
Association between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese women.15种已知或潜在的乳腺癌易感基因与中国女性乳腺癌风险之间的关联。
Cancer Biol Med. 2021 Oct 5;19(2):253-62. doi: 10.20892/j.issn.2095-3941.2021.0358.
7
Primary care physicians' knowledge and attitudes towards genetic testing for breast-ovarian cancer predisposition.初级保健医生对乳腺癌-卵巢癌易感性基因检测的知识和态度。
Ann Oncol. 2000 Sep;11(9):1131-5. doi: 10.1023/a:1008319114278.
8
The relationships among breast cancer-related prevention behavior, attitude, knowledge and fatalism in Chinese women with benign breast tumors.
Psychol Health Med. 2025 May 6:1-13. doi: 10.1080/13548506.2025.2486502.
9
Decision-making about genetic testing among women at familial risk for breast cancer.
Psychosom Med. 1997 Sep-Oct;59(5):459-66. doi: 10.1097/00006842-199709000-00001.
10
Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington.华盛顿西部不同女性群体对乳腺癌和卵巢癌易感性基因检测的态度及兴趣。
Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 2):369-75.

引用本文的文献

1
Personalizing Neoadjuvant Chemotherapy: The Impact of BRCA Variants on Pathologic Complete Response in Luminal B Breast Cancer.个性化新辅助化疗：BRCA 变异对 luminal B 型乳腺癌病理完全缓解的影响
Cancers (Basel). 2025 May 10;17(10):1619. doi: 10.3390/cancers17101619.

本文引用的文献

1
Parp-inhibitors in the therapeutic landscape of breast cancer patients with BRCA1 and BRCA2 pathogenic germline variants: An Italian consensus paper and critical review.BRCA1 和 BRCA2 种系致病性变异的乳腺癌患者治疗领域中的聚腺苷二磷酸核糖聚合酶抑制剂：意大利共识文件和批判性评价。
Cancer Treat Rev. 2024 Nov;130:102815. doi: 10.1016/j.ctrv.2024.102815. Epub 2024 Aug 21.
2
Breast Cancer Genetics: Diagnostics and Treatment.乳腺癌遗传学：诊断与治疗。
Genes (Basel). 2022 Sep 6;13(9):1593. doi: 10.3390/genes13091593.
3
Cancer Risks Associated With and Pathogenic Variants.
与 BRCA1/2 基因和致病变异相关的癌症风险。
J Clin Oncol. 2022 May 10;40(14):1529-1541. doi: 10.1200/JCO.21.02112. Epub 2022 Jan 25.
4
Attitudes toward Risk-Reducing Mastectomy and Risk-Reducing Salpingo-oophorectomy among Young, Unmarried, Healthy Women in Korea.韩国年轻、未婚健康女性对降低风险的乳房切除术和降低风险的输卵管卵巢切除术的态度。
Cancer Res Treat. 2022 Apr;54(2):375-382. doi: 10.4143/crt.2021.449. Epub 2021 Aug 9.
5
Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030.中国女性乳腺癌的发病率和死亡率：时间趋势及至2030年的预测
Cancer Biol Med. 2021 May 18;18(3):900-9. doi: 10.20892/j.issn.2095-3941.2020.0523.
6
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.BRCA1 和 BRCA2 基因突变携带者的乳腺癌、卵巢癌和对侧乳腺癌风险。
JAMA. 2017 Jun 20;317(23):2402-2416. doi: 10.1001/jama.2017.7112.
7
Genetic Testing and Counseling Among Patients With Newly Diagnosed Breast Cancer .新诊断乳腺癌患者的基因检测与咨询
JAMA. 2017 Feb 7;317(5):531-534. doi: 10.1001/jama.2016.16918.
8
BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.BRCA1 和 BRCA2 基因突变检测在年轻乳腺癌女性中的应用。
JAMA Oncol. 2016 Jun 1;2(6):730-6. doi: 10.1001/jamaoncol.2015.5941.
9
Attitude towards genetic testing for breast cancer susceptibility: a comparison of affected and unaffected women.乳腺癌易感性基因检测态度：患者与非患者女性的比较。
Eur J Cancer Care (Engl). 2010 May;19(3):360-8. doi: 10.1111/j.1365-2354.2009.01067.x. Epub 2009 Nov 13.
10
Acceptance, motivators, and barriers in attending breast cancer genetic counseling in Asians.
Cancer Detect Prev. 2005;29(5):412-8. doi: 10.1016/j.cdp.2005.06.009. Epub 2005 Sep 23.